Latest News about SPRY

Recent news which mentions SPRY

< Previous 1 2 Next >

ARS Pharma (SPRY) Q4 2025 Earnings Transcript

May 15, 2026

ARS Pharmaceuticals Q1 2026 Earnings Call Transcript

May 15, 2026

Earnings Scheduled For May 15, 2026

May 15, 2026

ARS Pharmaceuticals Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

May 15, 2026

Dow Settles Above 50,000: Investor Sentiment Improves, Fear Index Remains In 'Greed' Zone

May 15, 2026

ARS Pharma Sales Jump 3,040% in Q2

August 13, 2025

Earnings Scheduled For August 13, 2025

August 13, 2025

Earnings Outlook For ARS Pharmaceuticals

August 12, 2025

Jim Cramer Is All Aboard Union Pacific, But Shows No Love For Orphan Drugs

June 12, 2025

Earnings Scheduled For May 14, 2025

May 14, 2025

ARS Pharmaceuticals's Earnings: A Preview

May 13, 2025

12 Health Care Stocks Moving In Thursday's Intraday Session

March 20, 2025

Jabil Posts Better-Than-Expected Earnings, Joins Darden Restaurants, QXO, Five Below And Other Big Stocks Moving Higher On Thursday

March 20, 2025

Earnings Scheduled For March 20, 2025

March 20, 2025

FDA Approves ARS Pharmaceuticals' Lower Dose Neffy Nasal Spray For Emergency Allergy Treatment

March 06, 2025

Earnings Scheduled For November 13, 2024

November 13, 2024

Insights Ahead: ARS Pharmaceuticals's Quarterly Earnings

November 12, 2024

ARS Pharmaceuticals Inks Licensing Pact For Neffy Allergic Reaction Treatment, Analyst Sees Further Stock Upside Despite 200% Surge In 2024

November 11, 2024

Where ARS Pharmaceuticals Stands With Analysts

October 08, 2024

Analyst Ratings For ARS Pharmaceuticals

September 09, 2024

Newly Approved ARS Pharmaceuticals' Needle-Free Neffy Offers Convenience Over EpiPen For Allergic Reaction, But Real-World Efficacy Questioned

August 23, 2024

ARS Pharmaceuticals 'Neffy Uniquely Positioned With Potential To Change Allergy Treatment Paradigm For First Time In 40 years:' Analyst

August 20, 2024

Fabrinet Posts Strong Earnings, Joins Amer Sports, Hawaiian Holdings And Other Big Stocks Moving Higher On Tuesday

August 20, 2024

Looking Into ARS Pharmaceuticals's Recent Short Interest

August 19, 2024

Loar Holdings Posts Upbeat Results, Joins Nvidia, Clean Energy Fuels, Penumbra And Other Big Stocks Moving Higher On Tuesday

August 13, 2024

FDA Approves ARS Pharma's Once Rejected Neffy Nasal Spray Alternative To EpiPen For Emergency Allergy Treatment

August 09, 2024

< Previous 1 2 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.